For example, statins affect lipoprotein composition and disease risk by targeting a metabolic pathway (cholesterol synthesis); similarly, understanding the downstream pathways that mediate APOE4 disease risk might identify more tractable therapeutic targets for treating APOE4-mediated AD. The gene discussed is APOE; the disease is Alzheimer disease.